Evaluation of Modified Le Fort I Osteotomy for Treating Cleft Lip and Palate Patients

February 14, 2026 updated by: Alexandria University
Nine adults with Angle class III relation and persistent alveolar bone defect due to CL/P deformity were included. SLF-1 maxillary advancement was performed. Lateral profile analysis and alveolar bone defect volume were assessed before and after the surgery.

Study Overview

Study Type

Interventional

Enrollment (Actual)

9

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alexandria, Egypt, 21514
        • Faculty of Dentistry, Alexandria University, Champollion St., Azarita, Alexandria, Egypt

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Presence of a maxillary skeletal deformity requiring correction
  2. Presence of an alveolar cleft deformity not previously treated at the mixed dentition stage.
  3. Patients having an alveolar cleft previously treated but a residual deformity is still present.

Exclusion criteria:

  1. Class 1 occlusion
  2. Dental malocclusion not associated with dentofacial deformities.
  3. Medical contraindication to general anesthesia
  4. Psychological instability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: adults with Angle class III relation and persistent alveolar bone defect due to CL/P deformity
segmental Le Fort I (SLF-1) osteotomy technique for repair of facial deformities of cleft lip and palate patients, as regards to the stability and predictability and cleft-alveolar gap dimension changes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alveolar Gap Measurement
Time Frame: 6 months
CBCT DICOM images of the patient's scan were imported into 3D Slicer software (BWH, USA). Volume rendering was calculated based on selection of region between the base of the nose superiorly, and edges of the alveolar cleft inferiorly, posteriorly, anteriorly, and on both sides. Segmentation of air present in this region was done, and exported in Standard Tessellation Language (stl) file format. The volume of this file was calculated to give an estimate of volume of the alveolar defect, using Meshmixer™ Version 3.5.474 (Autodesk®, California, USA). 6 months' postoperative CBCT and preoperative CBCT. were compared to determine the amount of change.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
amount of planned maxillary advancement compared to actual amount of advancement achieved after the operation
Time Frame: 6 month
Planned amount of advancement was extracted from the digital planning procedure for each subject, and this was compared with the actual amount of advancement achieved from the surgery. This actual amount of advancement was calculated by superimposing the 3D-generated skulls of the preoperative CBCT on the 3D-generated skull of the postoperative CBCT, and a point placed on the upper first molar of each of the preoperative and postoperative CBCT. The distance between the two points is the amount of advancemenet achieved.
6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Actual)

January 1, 2023

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

February 14, 2026

First Submitted That Met QC Criteria

February 14, 2026

First Posted (Actual)

February 20, 2026

Study Record Updates

Last Update Posted (Actual)

February 20, 2026

Last Update Submitted That Met QC Criteria

February 14, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 0026-05/2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cleft Lip Palate

Clinical Trials on segmental Le Fort I (SLF-1) osteotomy

Subscribe